145 related articles for article (PubMed ID: 37629142)
1. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.
Choudhry M; Gamallat Y; Ghosh S; Bismar TA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629142
[TBL] [Abstract][Full Text] [Related]
2. Glycyl-tRNA Synthetase (GARS) Expression Is Associated with Prostate Cancer Progression and Its Inhibition Decreases Migration, and Invasion In Vitro.
Khosh Kish E; Gamallat Y; Choudhry M; Ghosh S; Seyedi S; Bismar TA
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901698
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
[TBL] [Abstract][Full Text] [Related]
4. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
5. Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.
Yang Q; Fan W; Zheng Z; Lin S; Liu C; Wang R; Li W; Zuo Y; Sun Y; Hu S; Chen M; Guo P; Pan J; Tian C; Zhu T; Diao C; Hao J; Yu W; Li L; Li Y; Guo W; Deng W; Wu X
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1533-1543. PubMed ID: 31301362
[TBL] [Abstract][Full Text] [Related]
6. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
7.
Choudhry M; Gamallat Y; Khosh Kish E; Seyedi S; Gotto G; Ghosh S; Bismar TA
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047027
[TBL] [Abstract][Full Text] [Related]
8. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
[TBL] [Abstract][Full Text] [Related]
9. ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro.
Gamallat Y; Zaaluk H; Kish EK; Abdelsalam R; Liosis K; Ghosh S; Bismar TA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163398
[TBL] [Abstract][Full Text] [Related]
10. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4.
Wu J; Miao J; Ding Y; Zhang Y; Huang X; Zhou X; Tang R
Biochem Cell Biol; 2019 Dec; 97(6):722-730. PubMed ID: 30970220
[TBL] [Abstract][Full Text] [Related]
11. CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
Wang X; Dong J; Li X; Cheng Z; Zhu Q
Oncogene; 2021 Jun; 40(25):4338-4351. PubMed ID: 34103682
[TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.
Nitschke K; Erben P; Waldbillig F; Abdelhadi A; Weis CA; Gottschalt M; Wahby S; Nuhn P; Boutros M; Michel MS; von Hardenberg J; Worst TS
World J Urol; 2020 Mar; 38(3):637-645. PubMed ID: 30701334
[TBL] [Abstract][Full Text] [Related]
14. WTAP promotes oesophageal squamous cell carcinoma development by decreasing CPSF4 expression in an m
Luo Q; Zhan X; Kuang Y; Sun M; Dong F; Sun E; Chen B
Med Oncol; 2022 Sep; 39(12):231. PubMed ID: 36175708
[TBL] [Abstract][Full Text] [Related]
15. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
Song Y; Sun K; Gong L; Shi L; Qin T; Wang S; Deng W; Chen W; Zheng F; Li G
Med Oncol; 2022 Dec; 40(1):62. PubMed ID: 36567417
[TBL] [Abstract][Full Text] [Related]
16. [High expression of MYBL2 promotes progression and predicts a poor survival outcome of prostate cancer].
Yang M; Zhu X; Shen Y; He Q; Qin Y; Shao Y; Yuan L; Ye H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1109-1118. PubMed ID: 36073208
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
19. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients.
Almami A; Hegazy SA; Nabbi A; Alshalalfa M; Salman A; Abou-Ouf H; Riabowol K; Bismar TA
Tumour Biol; 2016 Jul; 37(7):9731-8. PubMed ID: 26803516
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NEAT1 Regulates 5-Fu Sensitivity, Apoptosis and Invasion in Colorectal Cancer Through the MiR-150-5p/CPSF4 Axis.
Wang X; Jiang G; Ren W; Wang B; Yang C; Li M
Onco Targets Ther; 2020; 13():6373-6383. PubMed ID: 32669857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]